Evidence map›Paper›PMID 20425020›Full record

ReviewCurrent rheumatology reports2010

Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?

Ankoor Shah, Robert T Keenan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current rheumatology reports, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Impact ofNutrients · 2021
    Article
  6. Review
  7. Epidemiology of cardiac or orthopedic procedures in goutTherapeutic advances in musculoskeletal disease · 2021
    Article
  8. Gout and Progression of Aortic Stenosis.The American journal of medicine · 2020
    Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Association Between Gout and Aortic Stenosis.The American journal of medicine · 2017
    Article
  15. International journal of clinical and experimental pathology · 2017
    Article
  16. Hypouricemic effect of flaccidoside II in rodents.Journal of natural medicines · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. A profile of gout patients in Sarawak.Rheumatology international · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ankoor ShahDivision of Rheumatology and Immunology, Duke University School of Medicine, 301 Trent Drive, Durham, NC 27710, USA.
Robert T Keenan
Duke University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gout and hyperuricemia have long been suspected to be risk factors for cardiovascular disease. However, studies have frequently failed to distinguish whether these entities have an independent effect on cardiovascular risk or serve as markers for other risk factors. In vitro and animal studies suggest that uric acid is a biologically active compound that can increase inflammatory mediators known to lead to vascular damage. In contrast, uric acid also has potentially protective effects as a strong antioxidant, approaching the potency of vitamin C. Large clinical trials demonstrate a consistent relationship between elevated serum uric acid and a variety of cardiovascular diseases, although the strength of association varies greatly. We review the evidence for and against an independent role for hyperuricemia and/or gout in cardiovascular pathology.

Indexed as

AnimalsAntioxidantsCardiovascular DiseasesCells, CulturedClinical Trials as TopicComorbidityDisease Models, AnimalGoutHumansHyperuricemiaInflammation MediatorsMetabolic SyndromeRisk FactorsUric AcidAntioxidantsInflammation MediatorsUric Acid

Identifiers

PMID20425020
OpenAlexW2000261263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.